Primary Formulary Changes
August 10, 2023FDA Grants Accelerated Approval for Elrexfio (elranatamab-bcmm) for Relapsed or Refractory Multiple Myeloma
August 14, 2023Upcoming Formulary Changes
BeneCard PBF is committed to providing innovative clinical solutions, valuable trend management strategies, and the highest quality of service. We regularly conduct a review of our formulary to remain current with the ever-changing prescription drug landscape.
During this review process, we consider changes that occur with new FDA approvals (brand and generic) and the latest clinical information. This comprehensive review looks at each therapeutic category to identify clinically superior products at the lowest net cost. This process is essential to help control pharmaceutical spend as drug costs, particularly for already costly specialty medications, increase over time. Our goal when considering updates to our formularies is to improve member health outcomes while maximizing plan savings.
October 2023 Changes
The following changes to the Performance Formulary will go into effect on October 1, 2023.
Moved from Excluded to Tier 1 Generic | Most Common Indication/Use |
---|---|
GLATOPA | Multiple Sclerosis |
Moved from Excluded to Preferred | Most Common Indication/Use |
---|---|
OVIDREL | Infertility |
AZSTARYS | ADHD |
Moved from Excluded to Non-Preferred | Most Common Indication/Use |
---|---|
JAYPIRCA | Lymphoma |
ORSERDU | Breast Cancer |
FILSPARI | Proteinuria |
AUSTEDO XR | Tardive Dyskinesia |
DAYBUE | Rett Syndrome |
PRADAXA PELLETS | Anticoagulant |
SKYCLARYS | Friedreich’s Ataxia |
Moved from Non-Preferred to Excluded | Most Common Indication/Use |
---|---|
SUPREP | Bowel Prep |
XYREM | Narcolepsy |
Moved from Preferred to Excluded | Most Common Indication/Use |
---|---|
DIVIGEL | Menopausal Symptoms |
NOVAREL | Infertility |
Moved from Tier 1 Generic to Excluded | Most Common Indication/Use |
---|---|
CHORIONIC GONADOTROPIN | Infertility |
BeneCard PBF appreciates your trust and support in serving your healthcare needs through your pharmacy benefit program. If you have any questions, please contact your BeneCard PBF Account Executive, or call our Client Service Center at 1-877-587-2239.